Journal
TRANSLATIONAL ONCOLOGY
Volume 6, Issue 6, Pages 749-U392Publisher
ELSEVIER SCIENCE INC
DOI: 10.1593/tlo.13613
Keywords
-
Categories
Funding
- Myeloma Canada
- CancerCare Manitoba
- Canada Foundation for Innovation
- Province of Manitoba
- Canadian Institutes of Health Research
Ask authors/readers for more resources
Multiple myeloma (MM) is preceded by monoclonal gammopathy of undetermined significance (MGUS). Up to date, it is difficult to predict an individual's time to disease progression and the treatment response. To examine whether the nuclear telomeric architecture will unravel some of these questions, we carried out. Three-dimensional (3D) telomere analysis on samples from patients diagnosed with MGUS and MM, as well as from patients who went into relapse. Telomere signal intensity, number of telomere aggregates, nuclear volume, and the overall nuclear telomere distribution (a/c ratio) were analyzed. The telomeric profiles allowed for the differentiation of the disease stages. The telomeric profiles of myeloma cells obtained from blood and bone marrow aspirates were identical. Based on this study, we discuss the use of 3D telomere profiling as a potential future tool for risk stratification and personalized treatment decisions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available